The document this correction applies to
Timely disclosureWhat was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Earnings Summary for the Fiscal Year Ended June 2021 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2022 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2023 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2025 [Japanese GAAP] (Consolidated)
Open the original documentEarnings Summary for the Fiscal Year Ended June 2021: <Supplementary Materials, pages 17-18> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2022: <Supplementary Materials, pages 15-16> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2023: <Supplementary Materials, page 15> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2024: <Supplementary Materials, pages 15-16> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2025: <Supplementary Materials, page 15> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Notes to Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment
Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in the Nursing Care and Welfare Business / Value 223,293, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Total increase in property, plant and equipment and intangible assets / Value 835,688, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 534,097, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,369,786, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,347,676, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,160,355, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,347,676, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,160,355, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,190,188, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,020,083, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,190,188, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,020,083, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 407,207, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,391,790, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 407,207, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,391,790, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,294,148, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,738,144, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 735,612, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,473,757, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,294,148, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,738,144, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 735,612, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,473,757, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 445,131, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,736,461
Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in the Nursing Care and Welfare Business / Value 223,186, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Total increase in property, plant and equipment and intangible assets / Value 835,581, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 2,076,547, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,912,128, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,359,056, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,171,735, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,359,056, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,171,735, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,202,596, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,032,490, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,202,596, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,032,490, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 418,485, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,403,068, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 418,485, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,403,068, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,292,869, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,736,865, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 1,676,056, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 3,412,921, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,292,869, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,736,865, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 1,676,056, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 3,412,921, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 475,131, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,766,461
The corrections do not affect the consolidated or non-consolidated financial statements.
An internal review of disclosure documents for previous fiscal years identified errors in the aggregation of certain figures for increases in property, plant and equipment and intangible assets in the notes to the segment information.
| Item | Details |
|---|---|
| Disclosure subject to correction | Earnings Summary for the Fiscal Year Ended June 2021 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2022 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2023 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated), Earnings Summary for the Fiscal Year Ended June 2025 [Japanese GAAP] (Consolidated) |
| Location of correction | Earnings Summary for the Fiscal Year Ended June 2021: <Supplementary Materials, pages 17-18> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2022: <Supplementary Materials, pages 15-16> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2023: <Supplementary Materials, page 15> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2024: <Supplementary Materials, pages 15-16> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment, Earnings Summary for the Fiscal Year Ended June 2025: <Supplementary Materials, page 15> 3. Consolidated Financial Statements and Principal Notes (5) Notes to the Consolidated Financial Statements (Notes to Segment Information, etc.) 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reportable segment |
| Details of correction | Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in the Nursing Care and Welfare Business / Value 223,293, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Total increase in property, plant and equipment and intangible assets / Value 835,688, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 534,097, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,369,786, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,347,676, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,160,355, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,347,676, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,160,355, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,190,188, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,020,083, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,190,188, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,020,083, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 407,207, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,391,790, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 407,207, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,391,790, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,294,148, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,738,144, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 735,612, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,473,757, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,294,148, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,738,144, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 735,612, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,473,757, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 445,131, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,736,461 → Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in the Nursing Care and Welfare Business / Value 223,186, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Total increase in property, plant and equipment and intangible assets / Value 835,581, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 2,076,547, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2019 to 30 June 2020 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,912,128, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,359,056, Disclosure covered Fiscal year ended June 2021 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,171,735, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 3,359,056, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2020 to 30 June 2021 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 4,171,735, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,202,596, Disclosure covered Fiscal year ended June 2022 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,032,490, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 4,202,596, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2021 to 30 June 2022 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 5,032,490, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 418,485, Disclosure covered Fiscal year ended June 2023 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,403,068, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 418,485, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2022 to 30 June 2023 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 1,403,068, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,292,869, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,736,865, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 1,676,056, Disclosure covered Fiscal year ended June 2024 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 3,412,921, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in the Medical Equipment Sales Business / Value 1,292,869, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Total increase in property, plant and equipment and intangible assets / Value 1,736,865, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 1,676,056, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2023 to 30 June 2024 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 3,412,921, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets in adjustments / Value 475,131, Disclosure covered Fiscal year ended June 2025 / Target fiscal year 1 July 2024 to 30 June 2025 / Item Increase in property, plant and equipment and intangible assets recognized in the consolidated financial statements / Value 2,766,461 |
| Reason for correction | An internal review of disclosure documents for previous fiscal years identified errors in the aggregation of certain figures for increases in property, plant and equipment and intangible assets in the notes to the segment information. |
| Impact on Business Performance | The corrections do not affect the consolidated or non-consolidated financial statements. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.An internal review of disclosure documents for previous fiscal years identified errors in the aggregation of certain figures for increases in property, plant and equipment and intangible assets in the notes to the segment information.